These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8962412)

  • 1. Rescue therapy with mycophenolate mofetil. Mycophenolate Mofetil Renal Refractory Rejection Study Group.
    Tomlanovich SJ
    Transplant Proc; 1996 Dec; 28(6 Suppl 1):34-6. PubMed ID: 8962412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of mycophenolate mofetil in transplant recipients.
    Mele TS; Halloran PF
    Immunopharmacology; 2000 May; 47(2-3):215-45. PubMed ID: 10878291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: The Mycophenolate Mofetil Acute Renal Rejection Study Group.
    Transplantation; 1998 Jan; 65(2):235-41. PubMed ID: 9458021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of mycophenolate mofetil in kidney transplantation].
    Hrvacevic R; Ignjatovic Lj; Vavic N
    Vojnosanit Pregl; 2001; 58(4):415-9. PubMed ID: 11712223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group.
    Transplantation; 1996 Apr; 61(7):1029-37. PubMed ID: 8623181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycophenolate mofetil.
    Sollinger HW
    Kidney Int Suppl; 1995 Dec; 52():S14-7. PubMed ID: 8587275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rescue therapy with mycophenolate mofetil. The Mycophenolate Mofetil Renal Refractory Rejection Study Group.
    Clin Transplant; 1996 Feb; 10(1 Pt 2):131-5. PubMed ID: 8680050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purine metabolism and immunosuppressive effects of mycophenolate mofetil (MMF).
    Allison AC; Eugui EM
    Clin Transplant; 1996 Feb; 10(1 Pt 2):77-84. PubMed ID: 8680053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycophenolate mofetil for the treatment of refractory, acute, cellular renal transplant rejection. The Mycophenolate Mofetil Renal Refractory Rejection Study Group.
    Transplantation; 1996 Mar; 61(5):722-9. PubMed ID: 8607174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycophenolate mofetil (MMF) in heart transplantation: rejection prevention and treatment.
    Renlund DG; Gopinathan SK; Kfoury AG; Taylor DO
    Clin Transplant; 1996 Feb; 10(1 Pt 2):136-9. PubMed ID: 8680051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycophenolate mofetil in renal transplantation: 3-year results from the placebo-controlled trial. European Mycophenolate Mofetil Cooperative Study Group.
    Transplantation; 1999 Aug; 68(3):391-6. PubMed ID: 10459543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on preclinical and clinical experience with mycophenolate mofetil.
    Sollinger HW
    Transplant Proc; 1996 Dec; 28(6 Suppl 1):24-9. PubMed ID: 8962410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycophenolate mofetil in renal transplantation: results from the U.S. randomized trials.
    Danovitch GM
    Kidney Int Suppl; 1995 Dec; 52():S93-6. PubMed ID: 8587293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of the severity of acute rejection in the early phase after rat lung transplantation on the effectiveness of mycophenolate mofetil to treat chronic allograft rejection.
    von Suesskind-Schwendi M; Hirt SW; Diez C; Ruemmele P; Puehler T; Schmid C; Lehle K
    Eur J Cardiothorac Surg; 2012 Jul; 42(1):142-8. PubMed ID: 22398468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mycophenolate mofetil reduces late renal allograft loss independent of acute rejection.
    Ojo AO; Meier-Kriesche HU; Hanson JA; Leichtman AB; Cibrik D; Magee JC; Wolfe RA; Agodoa LY; Kaplan B
    Transplantation; 2000 Jun; 69(11):2405-9. PubMed ID: 10868649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mycophenolate mofetil: suggested guidelines for use in kidney transplantation.
    Behrend M
    BioDrugs; 2001; 15(1):37-53. PubMed ID: 11437674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of clinical experience with the novel immunosuppressive drug mycophenolate mofetil in renal transplantation.
    Behrend M
    Clin Nephrol; 1996 May; 45(5):336-41. PubMed ID: 8738667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW
    Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycophenolate mofetil versus azathioprine immunosuppressive regimens after lung transplantation: preliminary experience.
    Ross DJ; Waters PF; Levine M; Kramer M; Ruzevich S; Kass RM
    J Heart Lung Transplant; 1998 Aug; 17(8):768-74. PubMed ID: 9730425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preliminary risk-benefit assessment of mycophenolate mofetil in transplant rejection.
    Simmons WD; Rayhill SC; Sollinger HW
    Drug Saf; 1997 Aug; 17(2):75-92. PubMed ID: 9285199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.